Floatz logo

Sra-333

Dementia With Lewy Bodies (DLB)

First Affiliated Hospital of Zhejiang UniversityPhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Dementia With Lewy Bodies (DLB) cohort.

Asset / SponsorPhaseRating
Neflamapimod
EIP Pharma Inc
Phase 2BB
[18F]ACI-15916
AC Immune SA
Early Phase 1C
SDM-8
Universitaire Ziekenhuizen KU Leuven
N/AD
PE 2I
Universitaire Ziekenhuizen KU Leuven
N/AD
mk-6240
Universitaire Ziekenhuizen KU Leuven
N/AD
Florbetaben
University of Minnesota
D

Same molecule, other indications

Sra-333 is also rated in:

Alzheimer's DiseaseDormant
BBB
Indicative ·
74 / 100
View asset →
DementiaDormant
BBB
Indicative ·
74 / 100
View asset →
Mild Cognitive ImpairmentDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →